Last reviewed · How we verify
NCT05116696
Comparison of Outcomes of Patients With Stage IV Chronic Limb-threatening Ischemia and Colorectal Cancer
trial testing For chronic limb-threatening ischemia (CLTI) patients revascularisation surgery; for colorectal liver metastasis (CRLM) patients metastatic liver surgery in Chronic Limb-Threatening Ischemia in 836 participants. Completed in 15 October 2021.
1 September 2021
Quick facts
| Lead sponsor | Clinical Centre of Serbia |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 836 |
| Start date | 1 March 2021 |
| Primary completion | 1 September 2021 |
| Estimated completion | 15 October 2021 |
| Sites | 1 location across Serbia |
Drugs / interventions tested
- For chronic limb-threatening ischemia (CLTI) patients revascularisation surgery; for colorectal liver metastasis (CRLM) patients metastatic liver surgery
Conditions studied
- Chronic Limb-Threatening Ischemia — all drugs for Chronic Limb-Threatening Ischemia →
- Colorectal Carcinoma — all drugs for Colorectal Carcinoma →
- Colorectal Carcinoma Metastatic in the Liver — all drugs for Colorectal Carcinoma Metastatic in the Liver →
Sponsor
Clinical Centre of Serbia
Who can join
Eligibility, any sex, with Chronic Limb-Threatening Ischemia or Colorectal Carcinoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Colorectal cancer (CRC) and chronic limb-threatening ischemia (CLTI) are relatively frequent and potentially fatal diseases. However, studies that are comparing clinical outcomes between CRC and CLTI patients in more advanced stages of the disease are lacking. The study aim was to evaluate outcomes of patients with colorectal cancer liver metastases (CRLM) treated by curative-intent liver resection and CLTI patients according to wound, ischemia, foot infection (WIfI) classification by comparing the short- and long-term clinical outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05116696
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Limb-Threatening Ischemia
Currently open trials in the same condition.
- NCT07352800 — Safety of Antithrombotic Heparin Proteoglycan Mimetic APAC in Peripheral Arterial Occlusive Disease and Chronic Limb-thr · Phase 2 · recruiting
- NCT06879561 — Pressure Wire Guidance for Infrapopliteal Artery Interventions · NA · recruiting
- NCT06071429 — Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease · NA · recruiting
- NCT06656364 — Esprit BTK Post-Approval Study · NA · active not recruiting
- NCT07330635 — Chronic Wounds and Blood Circulation Detection · NA · recruiting
Other Clinical Centre of Serbia trials
Trials by the same sponsor.
- NCT06570785 — IOPS Technology During Cannnulation of Contralateral Limb in EVAR · not yet recruiting
- NCT06253312 — Treatment of TASC C and D Aortoiliac Lesions · recruiting
- NCT05857202 — Oxidative Stress and Inflammation Biomarkers in Surgically Treated Patients With Laryngeal Cancer · unknown
- NCT04388280 — Imaging vs. no Testing in Asymptomatic High-risk Diabetic Patients · NA · unknown
- NCT04165629 — Platelet Reactivity in PAD Undergoing Percutaneous Angioplasty · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05116696 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Clinical Centre of Serbia
- Last refreshed: 11 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05116696.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing